82 related articles for article (PubMed ID: 3277371)
1. Glucagon secretion in anorexia nervosa.
Kumai M; Tamai H; Fujii S; Nakagawa T; Aoki TT
Am J Clin Nutr; 1988 Feb; 47(2):239-42. PubMed ID: 3277371
[TBL] [Abstract][Full Text] [Related]
2. Impaired glucagon secretion to insulin-induced hypoglycemia in anorexia nervosa.
Fujii S; Tamai H; Kumai M; Takaichi Y; Nakagawa T; Aoki TT
Acta Endocrinol (Copenh); 1989 May; 120(5):610-5. PubMed ID: 2658451
[TBL] [Abstract][Full Text] [Related]
3. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
[TBL] [Abstract][Full Text] [Related]
4. The role of insulin, glucagon and growth hormone in the regulation of plasma glucose and free fatty acid levels in anorexia nervosa.
Blickle JF; Reville P; Stephan F; Meyer P; Demangeat C; Sapin R
Horm Metab Res; 1984 Jul; 16(7):336-40. PubMed ID: 6386641
[TBL] [Abstract][Full Text] [Related]
5. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
[TBL] [Abstract][Full Text] [Related]
6. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
7. Human pancreatic polypeptide responsiveness to insulin-induced hypoglycemia in anorexia nervosa.
Takeno K; Tamai H; Matsubayashi S; Kobayashi N; Nakagawa T; Yanaihara N
Horm Res; 1990; 33(5):190-3. PubMed ID: 2272611
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
[TBL] [Abstract][Full Text] [Related]
9. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
[TBL] [Abstract][Full Text] [Related]
10. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis.
O'Brien TD; Hayden DW; Johnson KH; Stevens JB
Vet Pathol; 1985 May; 22(3):250-61. PubMed ID: 3890345
[TBL] [Abstract][Full Text] [Related]
11. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy.
Tamai H; Takemura J; Kobayashi N; Matsubayashi S; Matsukura S; Nakagawa T
Metabolism; 1993 May; 42(5):581-4. PubMed ID: 8492713
[TBL] [Abstract][Full Text] [Related]
13. Eating attitudes and glucose tolerance in anorexia nervosa patients at 8-year followup compared to control subjects.
Casper RC; Pandey G; Jaspan JB; Rubenstein AH
Psychiatry Res; 1988 Sep; 25(3):283-99. PubMed ID: 3054985
[TBL] [Abstract][Full Text] [Related]
14. Role of alpha and beta cells in the impaired glucose tolerance of thalassaemic subjects.
Passariello N; Paolisso G; Sgambato S; D'Onofrio F
Diabete Metab; 1987; 13(4):436-40. PubMed ID: 3315764
[TBL] [Abstract][Full Text] [Related]
15. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
16. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
Abdul-Ghani M; DeFronzo RA
J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375
[TBL] [Abstract][Full Text] [Related]
17. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
18. [Changes in the glucagon and growth hormone levels in the blood plasma of healthy persons and of patients with disordered glucose tolerance after insulin administration].
Tikhonova NE; Alekseeva GG
Probl Endokrinol (Mosk); 1986; 32(1):22-5. PubMed ID: 3513155
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.
Stock S; Leichner P; Wong AC; Ghatei MA; Kieffer TJ; Bloom SR; Chanoine JP
J Clin Endocrinol Metab; 2005 Apr; 90(4):2161-8. PubMed ID: 15657373
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostaglandin E1 and prostaglandin F2alpha on insulin and glucagon plasma levels during the intravenous glucose tolerance test in man.
Giugliano D; Torella R; Improta L; D'Onofrio F
Diabete Metab; 1978 Sep; 4(3):187-91. PubMed ID: 710679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
